The purpose of this study is to assess ZPL389 efficacy and safety in subjects with moderate to severe atopic dermatitis.
|Clinical Study Identifier||NCT03517566|
|Last Modified on||2 September 2020|
Select a piece of text and start making personal notes.
Congrats! You have your own personal workspace now.